- $18.33m
- $14.04m
- $13.48m
2019 June 30th | 2020 June 30th | C2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.983 | 1.95 | 3.42 | 7.27 | 13.5 |
Cost of Revenue | |||||
Gross Profit | 0.558 | 0.808 | 1.96 | 6.03 | 9.22 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 6.57 | 6.87 | 9.34 | 13.3 | 42.3 |
Operating Profit | -5.58 | -4.92 | -5.92 | -6 | -28.8 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -5.58 | -4.99 | -6.09 | -5.97 | -28.6 |
Net Income After Taxes | -5.58 | -4.99 | -6.09 | -5.97 | -28.6 |
Net Income Before Extraordinary Items | |||||
Net Income | -5.58 | -4.99 | -6.09 | -5.97 | -28.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.58 | -4.99 | -6.09 | -5.97 | -28.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.861 | -0.721 | -0.844 | -0.488 | -0.928 |
Dividends per Share |